MedTrace Logo

A Study of Minirin Melt in Patients With Nocturia

NCT01212224 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2187

Last updated 2014-01-06

No results posted yet for this study

Summary

This is a confirmation of safety profile for Minirin Melt in clinical practice.

Conditions

  • Nocturia

Sponsors & Collaborators

  • Ferring Pharmaceuticals

    lead INDUSTRY

Principal Investigators

  • Clinical Development Support · Ferring Pharmaceuticals

Eligibility

Min Age
18 Years
Max Age
64 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-01-31
Primary Completion
2013-03-31
Completion
2013-12-31

Countries

  • Czechia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01212224 on ClinicalTrials.gov